Prevest Denpro Ltd Valuation
PREVEST · Healthcare · Current price ₹384.9
Is Prevest Denpro Ltd undervalued?
DocStoX estimates the fair value of Prevest Denpro Ltd at ₹338 per share, versus the current market price of ₹385. That puts the stock about -12.2% above our fair-value estimate, which we read as "Fairly Valued". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹129), Relative P/E (₹847), Graham floor (₹175). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹129 (bear) to ₹338 (base) to ₹847 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
Prevest Denpro Ltd trades at a P/E of 25.4x and a P/B of 3.8x, with a dividend yield of 0.3%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on Prevest Denpro Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.